BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Cipla Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500087
ISIN Demat
INE059A01026
Book Value (Rs)
411.5600262
NSE Symbol
CIPLA
Divident Yield %
1.17
Market Cap
(Rs In Cr.)
110,790
P/E (TTM)
21.31
EPS (TTM)
64.35
Face Value
(Rs)
2
Back
Cipla consolidated net profit rises 3.73% in the September 2025 quarter
30-Oct-25   Hrs IST

Net profit of Cipla rose 3.73% to Rs 1351.17 crore in the quarter ended September 2025 as against Rs 1302.53 crore during the previous quarter ended September 2024. Sales rose 6.98% to Rs 7447.42 crore in the quarter ended September 2025 as against Rs 6961.22 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales7447.426961.22 7
OPM %25.4427.09 -
PBDT2150.522060.80 4
PBT1853.531789.06 4
NP1351.171302.53 4

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)